MSN Laboratories, an Indian-based leader in pharmaceutical products, recently opened a Jamaican subsidiary.
This is the first step in its broader strategy to enhance healthcare in the Caribbean.
The new Jamaican subsidiary will serve as a hub for the delivery of essential medicines to the region. These will initially include medicines for cardiovascular diseases, diabetes, oncology, infectious diseases, and central nervous system disorders.
comments powered by Disqus
All feeds
